Everence Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.7M Buy
55,943
+1,130
+2% +$263K 0.83% 18
2025
Q4
$11.3M Hold
54,813
0.67% 21
2025
Q3
$10.2M Buy
54,813
+5,152
+10% +$883K 0.61% 23
2025
Q2
$7.59M Sell
49,661
-15,670
-24% -$2.41M 0.49% 29
2025
Q1
$10.8M Sell
65,331
-2,510
-4% -$393K 0.74% 21
2024
Q4
$9.81M Sell
67,841
-5,500
-7% -$852K 0.64% 25
2024
Q3
$11.9M Buy
73,341
+2,560
+4% +$408K 0.75% 21
2024
Q2
$10.2K Hold
70,781
0.71% 25
2024
Q1
$11.2K Hold
70,781
0.74% 23
2023
Q4
$11.1M Buy
70,781
+5,812
+9% +$891K 0.79% 22
2023
Q3
$10.1K Sell
64,969
-7,090
-10% -$1.17M 0.79% 20
2023
Q2
$11.2M Hold
72,059
0.91% 17
2023
Q1
$11.2K Buy
72,059
+1,880
+3% +$304K 0.91% 16
2022
Q4
$12.4K Buy
70,179
+910
+1% +$157K 1.07% 13
2022
Q3
$11.3M Hold
69,269
1.05% 12
2022
Q2
$12.3M Hold
69,269
1.1% 10
2022
Q1
$12.3M Sell
69,269
-140
-0.2% -$23.8K 0.94% 15
2021
Q4
$11.9M Buy
69,409
+9,230
+15% +$1.51M 0.88% 16
2021
Q3
$9.72M Hold
60,179
0.8% 17
2021
Q2
$9.91M Hold
60,179
0.82% 17
2021
Q1
$9.89M Hold
60,179
0.9% 15
2020
Q4
$9.47M Sell
60,179
-6,570
-10% -$970K 0.92% 13
2020
Q3
$9.94M Sell
66,749
-7,350
-10% -$1.09M 1.09% 11
2020
Q2
$11M Hold
74,099
1.3% 11
2020
Q1
$9.72M Hold
74,099
1.37% 10
2019
Q4
$10.8M Buy
74,099
+7,348
+11% +$997K 1.61% 7
2019
Q3
$8.64M Hold
66,751
1.4% 6
2019
Q2
$9.3M Buy
66,751
+1,570
+2% +$217K 1.54% 6
2019
Q1
$9.11M Buy
65,181
+8,679
+15% +$1.16M 1.59% 6
2018
Q4
$7.29M Hold
56,502
1.69% 5
2018
Q3
$7.81M Hold
56,502
1.55% 7
2018
Q2
$6.86M Sell
56,502
-3,850
-6% -$480K 1.45% 7
2018
Q1
$7.73M Sell
60,352
-2,030
-3% -$274K 1.71% 7
2017
Q4
$8.72M Buy
62,382
+3,110
+5% +$433K 1.91% 6
2017
Q3
$7.71M Hold
59,272
1.76% 5
2017
Q2
$7.84M Hold
59,272
1.92% 3
2017
Q1
$7.38M Hold
59,272
1.94% 3
2016
Q4
$6.83M Sell
59,272
-1,567
-3% -$181K 1.96% 3
2016
Q3
$7.19M Buy
60,839
+2,510
+4% +$305K 2.13% 4
2016
Q2
$7.08M Sell
58,329
-1,620
-3% -$184K 2.17% 3
2016
Q1
$6.49M Buy
59,949
+3,770
+7% +$390K 2.02% 3
2015
Q4
$5.77M Hold
56,179
1.87% 3
2015
Q3
$5.24M Hold
56,179
1.81% 4
2015
Q2
$5.47M Hold
56,179
1.77% 4
2015
Q1
$5.76M Hold
56,179
1.93% 4
2014
Q4
$5.88M Sell
56,179
-1,160
-2% -$122K 2.01% 3
2014
Q3
$5.95M Hold
57,339
2.17% 3
2014
Q2
$6M Hold
57,339
2.23% 3
2014
Q1
$5.63M Hold
57,339
2.22% 3
2013
Q4
$5.25M Sell
57,339
-5,100
-8% -$470K 2.12% 4
2013
Q3
$5.41M Sell
62,439
-915
-1% -$82.1K 2.32% 2
2013
Q2
$5.44M Buy
+63,354
New +$5.38M 2.46% 2

Other funds holding JNJ

Everence Capital Management's JNJ Position: Q1 2026 in Review

Everence Capital Management increased its Johnson & Johnson (JNJ) stake by 2.1% in Q1 2026, buying an estimated $263K and bringing the position to 55,943 shares worth $13.7M. The position accounts for 0.83% of the portfolio, ranked #18.

Everence Capital Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Everence Capital Management held 55,943 shares of Johnson & Johnson worth $13.7M as of Q1 2026.
  • Everence Capital Management bought 1,130 Johnson & Johnson shares in Q1 2026, an estimated $263K.
  • Johnson & Johnson made up 0.83% of Everence Capital Management's portfolio in Q1 2026, its #18 holding.
  • Everence Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.